HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lukas J A Stalpers Selected Research

Spinal Cord Compression

10/2015Single-Fraction Versus 5-Fraction Radiation Therapy for Metastatic Epidural Spinal Cord Compression in Patients With Limited Survival Prognoses: Results of a Matched-Pair Analysis.
4/2011Validation of a score predicting post-treatment ambulatory status after radiotherapy for metastatic spinal cord compression.
2/2011Final results of a prospective study comparing the local control of short-course and long-course radiotherapy for metastatic spinal cord compression.
1/2009Preliminary results of spinal cord compression recurrence evaluation (score-1) study comparing short-course versus long-course radiotherapy for local control of malignant epidural spinal cord compression.
11/2008A score predicting posttreatment ambulatory status in patients irradiated for metastatic spinal cord compression.
9/2008Prognostic factors for functional outcome and survival after reirradiation for in-field recurrences of metastatic spinal cord compression.
4/2007Improved posttreatment functional outcome is associated with better survival in patients irradiated for metastatic spinal cord compression.
2/2007Functional outcome and survival after radiotherapy of metastatic spinal cord compression in patients with cancer of unknown primary.
1/2007Outcome after radiotherapy alone for metastatic spinal cord compression in patients with oligometastases.
1/2007Radiotherapy of metastatic spinal cord compression in very elderly patients.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lukas J A Stalpers Research Topics

Disease

28Neoplasms (Cancer)
01/2022 - 10/2004
22Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022 - 03/2008
22Spinal Cord Compression
10/2015 - 12/2004
16Hyperthermia
01/2022 - 03/2008
11Brain Neoplasms (Brain Tumor)
05/2018 - 09/2007
9Glioma (Gliomas)
01/2019 - 01/2004
7Prostatic Neoplasms (Prostate Cancer)
03/2022 - 02/2006
7Glioblastoma (Glioblastoma Multiforme)
01/2018 - 01/2004
6Neoplasm Metastasis (Metastasis)
11/2019 - 07/2006
6Breast Neoplasms (Breast Cancer)
11/2019 - 01/2006
5Meningioma (Meningiomas)
01/2021 - 09/2007
5Carcinoma (Carcinomatosis)
07/2014 - 10/2004
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2018 - 05/2006
2Lymphatic Metastasis
01/2022 - 09/2021
2Lymphoma (Lymphomas)
01/2007 - 07/2006
1Genetic Predisposition to Disease (Genetic Predisposition)
01/2022
1Lung Neoplasms (Lung Cancer)
05/2018
1Genomic Instability
01/2018
1AIDS-Related Complex (ARC)
10/2016
1Endometrial Neoplasms (Endometrial Cancer)
03/2015
1Adenocarcinoma
07/2014
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2014
1Acquired Immunodeficiency Syndrome (AIDS)
04/2013
1Genetic Translocation (Chromosomal Translocation)
01/2013
1Tics (Tic)
12/2011
1Pain (Aches)
06/2011
1Cystitis
06/2011
1Transitional Cell Carcinoma
10/2010
1Urinary Bladder Neoplasms (Bladder Cancer)
10/2010
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
04/2010
1Disease Progression
12/2009
1Hypoxia (Hypoxemia)
11/2009

Drug/Important Bio-Agent (IBA)

6Cisplatin (Platino)FDA LinkGeneric
01/2022 - 11/2005
5Temozolomide (Temodar)FDA LinkGeneric
01/2017 - 11/2007
3DNA (Deoxyribonucleic Acid)IBA
08/2018 - 01/2017
2Biological ProductsIBA
01/2022 - 01/2020
2Biomarkers (Surrogate Marker)IBA
09/2021 - 01/2017
2Proteins (Proteins, Gene)FDA Link
12/2015 - 03/2012
2Bevacizumab (Avastin)FDA Link
02/2015 - 12/2011
2Diphosphonates (Bisphosphonates)IBA
02/2011 - 01/2009
2salicylhydroxamic acid (SHAM)IBA
11/2009 - 09/2007
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2009 - 09/2007
1squamous cell carcinoma-related antigenIBA
09/2021
1olaparibIBA
04/2021
1Immune Checkpoint InhibitorsIBA
11/2019
1monocrystalline iron oxide nanoparticle (MION)IBA
11/2019
1AntibodiesIBA
11/2019
1lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA
08/2018
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
08/2018
1Heat-Shock Proteins (Heat-Shock Protein)IBA
08/2018
1DNA-Activated Protein KinaseIBA
08/2018
1binimetinibIBA
01/2018
1Radiation-Sensitizing AgentsIBA
04/2017
1Poly(ADP-ribose) Polymerase InhibitorsIBA
04/2017
1MK 2206IBA
01/2017
1EverolimusFDA Link
11/2016
1AZD 6244IBA
11/2016
1PLX 4720IBA
11/2016
1MTOR InhibitorsIBA
11/2016
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2016
1Annexin A5IBA
02/2016
1GalactosidasesIBA
02/2016
1Oncogene Proteins (Oncogene Protein)IBA
12/2015
1Therapeutic UsesIBA
03/2014
1PlatinumIBA
02/2014
1Cytostatic AgentsIBA
05/2013
1PyrimidinesIBA
05/2013
1Poly Adenosine Diphosphate RiboseIBA
05/2013
11,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
01/2013
18- dibenzothiophen- 4- yl- 2- morpholin- 4- yl- chromen- 4- oneIBA
01/2013
1Alkylating AgentsIBA
01/2013
1Anticonvulsants (Antiepileptic Drugs)IBA
03/2012
1Valproic Acid (Depakote)FDA LinkGeneric
03/2012
1Pharmaceutical PreparationsIBA
12/2011
1Oxygen (Dioxygen)IBA
08/2011
1SolutionsIBA
06/2011
1Chondroitin Sulfates (Chondroitin Sulfate)IBA
06/2011
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
11/2009
1Angiogenesis InhibitorsIBA
11/2009
1pegaptanib (Macugen)FDA Link
11/2009

Therapy/Procedure

72Radiotherapy
03/2022 - 04/2002
10Therapeutics
09/2021 - 10/2006
6Hysterectomy
01/2022 - 07/2014
5Drug Therapy (Chemotherapy)
04/2017 - 01/2013
4Aftercare (After-Treatment)
01/2021 - 10/2004
4Brachytherapy
03/2015 - 10/2004
3Lymph Node Excision (Lymph Node Dissection)
01/2022 - 07/2014
3Chemoradiotherapy
03/2020 - 02/2015
3Re-Irradiation
09/2008 - 09/2005
2Contraindications
03/2020 - 04/2017
2Proton Therapy
01/2018 - 07/2016
2Adjuvant Chemotherapy
07/2014 - 09/2007
1Adjuvant Chemoradiotherapy
01/2022
1Duration of Therapy
01/2022
1Trachelectomy
09/2019
1Patient Positioning
10/2016
1Salpingo-oophorectomy
03/2015
1Adjuvant Radiotherapy
07/2014
1Neoadjuvant Therapy
02/2014
1Intravesical Administration
06/2011